Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
1996-12-9
|
| pubmed:abstractText |
Paroxysmal atrial fibrillation (PAF) and paroxysmal supraventricular tachycardia (PSVT) leading to hemodynamic compromise are among the most common reasons for admission to the coronary care unit (CCU) and need prompt and efficient therapy. Direct current cardioversion is the therapy of choice, but if found contraindicated or unavailable some antiarrhythmic agents are usually given to restore sinus rhythm. Many of these drugs have obvious limitations, especially in patients with acute myocardial infarction and/or heart failure.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0160-9289
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
19
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
563-6
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8818437-Aged,
pubmed-meshheading:8818437-Amiodarone,
pubmed-meshheading:8818437-Anti-Arrhythmia Agents,
pubmed-meshheading:8818437-Electric Countershock,
pubmed-meshheading:8818437-Female,
pubmed-meshheading:8818437-Humans,
pubmed-meshheading:8818437-Injections, Intravenous,
pubmed-meshheading:8818437-Male,
pubmed-meshheading:8818437-Middle Aged,
pubmed-meshheading:8818437-Tachycardia, Supraventricular,
pubmed-meshheading:8818437-Treatment Outcome
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias.
|
| pubmed:affiliation |
Department of Cardiology, Postgraduate Medical School, Warsaw, Poland.
|
| pubmed:publicationType |
Journal Article
|